Fenofibrate Tablet
Product Images NDC 51655-856

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 51655-856). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 856 52 Rev A 02 23)

Label for Fenofibrate Tablets USP 160 mg, containing 30 tablets in a prescription package. The label includes storage instructions to keep at controlled room temperature and to protect from moisture. It is labeled for repackaging by Northwind Pharmaceuticals, Indianapolis, IN, with various batch and identification codes.*

FDA Label Image

Fenofibrate Structural Formula (95807ea5 4d6b 4a8a 90e1 624ab1e870a6 01)

Chemical structure diagram of fenofibrate, showing its molecular formula with distinct aromatic rings, ester groups, chlorine, and various carbon and oxygen atoms typical of the fenofibrate molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.